LARISSA LOBATO: Open Payments
NPI 1023367166 · SHREWSBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,340 in 39 payments from 11 companies in 2025. Trend: 2023 $2,064 · 2024 $1,651 · 2025 $1,340
Food & beverage: $1,340
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 22 | $322 |
| REVANCE THERAPEUTICS, INC. | 4 | $274 |
| Lilly USA, LLC | 2 | $144 |
| Janssen Biotech, Inc. | 2 | $139 |
| Arcutis Biotherapeutics, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $124 |
| ViiV Healthcare Company | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: WATCHMAN FLX, DAXXIFY, TREMFYA, EBGLYSS, DUPIXENT, CABENUVA, COSENTYX, TALTZ.
Industry payments across NJ — which companies pay providers there.
